{"id":240956,"date":"2025-07-15T09:10:51","date_gmt":"2025-07-15T07:10:51","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=240956"},"modified":"2025-07-15T09:16:57","modified_gmt":"2025-07-15T07:16:57","slug":"posicionament-fefac-aranzels-medicament-sector-farmaceutic","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/","title":{"rendered":"Posicionament de la FEFAC davant l&#8217;aplicaci\u00f3 d&#8217;aranzels als medicaments"},"content":{"rendered":"\n<p>Des de la <strong>FEFAC<\/strong> manifestem la nostra preocupaci\u00f3 davant l\u2019impacte que poden tenir les mesures comercials internacionals, com l\u2019aplicaci\u00f3 d\u2019aranzels, sobre l\u2019acc\u00e9s als medicaments i a la tecnologia sanit\u00e0ria.<\/p>\n\n\n\n<p>Tal com ha expressat recentment <strong>Antonio Torres<\/strong>, president de la FEFAC i vicepresident de PIMEC, en una<strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/x.com\/FEFAC_farmacia\/status\/1945005518365298823\" target=\"_blank\" rel=\"noreferrer noopener\"> intervenci\u00f3 a Telecinco:<\/a><\/span><\/em><\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Els medicaments i la tecnologia sanit\u00e0ria s\u00f3n b\u00e9ns essencials i estrat\u00e8gics<\/strong>, directament vinculats a un dret fonamental: la salut. <strong>No poden quedar atrapats en conflictes comercials ni ser objecte de tensions econ\u00f2miques internacionals.<\/strong><\/li>\n\n\n\n<li>Cal una <strong>Europa m\u00e9s proactiva<\/strong>, que protegeixi el <strong>teixit productiu, de distribuci\u00f3 i de dispensaci\u00f3<\/strong> que garanteix l\u2019atenci\u00f3 sanit\u00e0ria a la ciutadania.<\/li>\n<\/ol>\n\n\n\n<h4 class=\"wp-block-heading\">Missatge a les administracions<\/h4>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Necessitem un <strong>entorn estable<\/strong> que permeti a les farm\u00e0cies continuar fent la seva tasca amb garanties. <strong>La salut no pot ser moneda de canvi en cap guerra comercial.<\/strong><\/li>\n\n\n\n<li><strong>La farm\u00e0cia sempre hi \u00e9s<\/strong>, per\u00f2 si no se la cuida, pot deixar d\u2019estar-hi. Aix\u00f2 ja passa a moltes zones d\u2019Espanya, especialment en <strong>entorns rurals o a\u00efllats<\/strong>, afectats per problemes de <strong>solv\u00e8ncia econ\u00f2mica, conciliaci\u00f3, relleu generacional o c\u00e0rrega burocr\u00e0tica.<\/strong><\/li>\n\n\n\n<li>Es tracta d\u2019un <strong>problema global amb impacte local<\/strong>, que exigeix una resposta <strong>immediata, coordinada i amb visi\u00f3 estrat\u00e8gica<\/strong> per part dels governs <strong>espanyol, catal\u00e0 i europeu<\/strong>.<\/li>\n<\/ol>\n\n\n\n<h4 class=\"wp-block-heading\">Missatge a la ciutadania<\/h4>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Tots els ciutadans tenen dret a la salut<\/strong>, i per tant, a accedir als medicaments <strong>amb seguretat, continu\u00eftat i preus justos.<\/strong><\/li>\n\n\n\n<li><strong>Les farm\u00e0cies estem al costat de la gent<\/strong>, aplicant totes les eines disponibles per atendre les seves necessitats i problemes de salut.<\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"es\" dir=\"ltr\">El <a href=\"https:\/\/twitter.com\/hashtag\/farmac%C3%A9utico?src=hash&amp;ref_src=twsrc%5Etfw\">#farmac\u00e9utico<\/a> Antoni Torres ha intervenido en La Mirada Cr\u00edtica de <a href=\"https:\/\/twitter.com\/telecincoes?ref_src=twsrc%5Etfw\">@telecincoes<\/a> para hablar de c\u00f3mo afectan los aranceles de <a href=\"https:\/\/twitter.com\/hashtag\/Trump?src=hash&amp;ref_src=twsrc%5Etfw\">#Trump<\/a> y <a href=\"https:\/\/twitter.com\/hashtag\/EEUU?src=hash&amp;ref_src=twsrc%5Etfw\">#EEUU<\/a> a los <a href=\"https:\/\/twitter.com\/hashtag\/medicamentos?src=hash&amp;ref_src=twsrc%5Etfw\">#medicamentos<\/a> de venta En Espa\u00f1a.<br>\ud83d\udcfa Empieza en el minuto 1:03:17<br>\ud83d\udd17 <a href=\"https:\/\/t.co\/rSP8Va2pC0\">https:\/\/t.co\/rSP8Va2pC0<\/a><\/p>&mdash; FEFAC (@FEFAC_farmacia) <a href=\"https:\/\/twitter.com\/FEFAC_farmacia\/status\/1945005518365298823?ref_src=twsrc%5Etfw\">July 15, 2025<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Not\u00edcia relacionada<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-fefac wp-block-embed-fefac\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"pJRUp6Ndwm\"><a href=\"https:\/\/fefac.cat\/empresarial\/impacte-aranzels-sector-farmaceutic\/\">&#8220;La salut no pot ser moneda de canvi&#8221;: l\u2019impacte dels aranzels en el sector farmac\u00e8utic i la farm\u00e0cia comunit\u00e0ria<\/a><\/blockquote><iframe class=\"wp-embedded-content lazyload\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;&#8220;La salut no pot ser moneda de canvi&#8221;: l\u2019impacte dels aranzels en el sector farmac\u00e8utic i la farm\u00e0cia comunit\u00e0ria&#8221; &#8212; FEFAC\" data-src=\"https:\/\/fefac.cat\/empresarial\/impacte-aranzels-sector-farmaceutic\/embed\/#?secret=LQJpBiB0rq#?secret=pJRUp6Ndwm\" data-secret=\"pJRUp6Ndwm\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" data-load-mode=\"1\"><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Des de la FEFAC manifestem la nostra preocupaci\u00f3 davant l\u2019impacte que poden tenir les mesures comercials internacionals, com l\u2019aplicaci\u00f3 d\u2019aranzels, sobre l\u2019acc\u00e9s als medicaments i a la tecnologia sanit\u00e0ria.<\/p>\n","protected":false},"author":2313,"featured_media":240958,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2066,2075,2067,10,11,12,13,14,15,294,101],"tags":[136,2952,2953],"class_list":["post-240956","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-recull-de-premsa","category-notes-premsa","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-politica-sanitaria","category-sanitaria","tag-medicaments","tag-trump","tag-aranzels"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Posicionament de la FEFAC davant l&#039;aplicaci\u00f3 d&#039;aranzels als medicamentsen el sector farmac\u00e8utic<\/title>\n<meta name=\"description\" content=\"Aquesta setmana, el president de la FEFAC, Antoni Torres, ha intervingut en televisi\u00f3 per alertar sobre les conseq\u00fc\u00e8ncies que pot tenir la nova pol\u00edtica d\u2019aranzels impulsada pel president Trump en el sector farmac\u00e8utic\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Posicionament de la FEFAC davant l&#039;aplicaci\u00f3 d&#039;aranzels als medicamentsen el sector farmac\u00e8utic\" \/>\n<meta property=\"og:description\" content=\"Aquesta setmana, el president de la FEFAC, Antoni Torres, ha intervingut en televisi\u00f3 per alertar sobre les conseq\u00fc\u00e8ncies que pot tenir la nova pol\u00edtica d\u2019aranzels impulsada pel president Trump en el sector farmac\u00e8utic\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T07:10:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-15T07:16:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2025\/07\/trump-aranzels-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Posicionament de la FEFAC davant l&#8217;aplicaci\u00f3 d&#8217;aranzels als medicaments\",\"datePublished\":\"2025-07-15T07:10:51+00:00\",\"dateModified\":\"2025-07-15T07:16:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/\"},\"wordCount\":300,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/trump-aranzels-2.jpg\",\"keywords\":[\"medicaments\",\"Trump\",\"aranzels\"],\"articleSection\":[\"Actualitat\",\"Recull de premsa\",\"Notes de premsa\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Pol\u00edtica sanit\u00e0ria\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/\",\"name\":\"Posicionament de la FEFAC davant l'aplicaci\u00f3 d'aranzels als medicamentsen el sector farmac\u00e8utic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/trump-aranzels-2.jpg\",\"datePublished\":\"2025-07-15T07:10:51+00:00\",\"dateModified\":\"2025-07-15T07:16:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"Aquesta setmana, el president de la FEFAC, Antoni Torres, ha intervingut en televisi\u00f3 per alertar sobre les conseq\u00fc\u00e8ncies que pot tenir la nova pol\u00edtica d\u2019aranzels impulsada pel president Trump en el sector farmac\u00e8utic\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/trump-aranzels-2.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/trump-aranzels-2.jpg\",\"width\":800,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Posicionament de la FEFAC davant l&#8217;aplicaci\u00f3 d&#8217;aranzels als medicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Posicionament de la FEFAC davant l'aplicaci\u00f3 d'aranzels als medicamentsen el sector farmac\u00e8utic","description":"Aquesta setmana, el president de la FEFAC, Antoni Torres, ha intervingut en televisi\u00f3 per alertar sobre les conseq\u00fc\u00e8ncies que pot tenir la nova pol\u00edtica d\u2019aranzels impulsada pel president Trump en el sector farmac\u00e8utic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/","og_locale":"ca_ES","og_type":"article","og_title":"Posicionament de la FEFAC davant l'aplicaci\u00f3 d'aranzels als medicamentsen el sector farmac\u00e8utic","og_description":"Aquesta setmana, el president de la FEFAC, Antoni Torres, ha intervingut en televisi\u00f3 per alertar sobre les conseq\u00fc\u00e8ncies que pot tenir la nova pol\u00edtica d\u2019aranzels impulsada pel president Trump en el sector farmac\u00e8utic","og_url":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/","og_site_name":"FEFAC","article_published_time":"2025-07-15T07:10:51+00:00","article_modified_time":"2025-07-15T07:16:57+00:00","og_image":[{"width":800,"height":450,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2025\/07\/trump-aranzels-2.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Posicionament de la FEFAC davant l&#8217;aplicaci\u00f3 d&#8217;aranzels als medicaments","datePublished":"2025-07-15T07:10:51+00:00","dateModified":"2025-07-15T07:16:57+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/"},"wordCount":300,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2025\/07\/trump-aranzels-2.jpg","keywords":["medicaments","Trump","aranzels"],"articleSection":["Actualitat","Recull de premsa","Notes de premsa","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","Pol\u00edtica sanit\u00e0ria","Sanit\u00e0ria"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/","url":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/","name":"Posicionament de la FEFAC davant l'aplicaci\u00f3 d'aranzels als medicamentsen el sector farmac\u00e8utic","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2025\/07\/trump-aranzels-2.jpg","datePublished":"2025-07-15T07:10:51+00:00","dateModified":"2025-07-15T07:16:57+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"Aquesta setmana, el president de la FEFAC, Antoni Torres, ha intervingut en televisi\u00f3 per alertar sobre les conseq\u00fc\u00e8ncies que pot tenir la nova pol\u00edtica d\u2019aranzels impulsada pel president Trump en el sector farmac\u00e8utic","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2025\/07\/trump-aranzels-2.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2025\/07\/trump-aranzels-2.jpg","width":800,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/posicionament-fefac-aranzels-medicament-sector-farmaceutic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Posicionament de la FEFAC davant l&#8217;aplicaci\u00f3 d&#8217;aranzels als medicaments"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/240956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=240956"}],"version-history":[{"count":3,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/240956\/revisions"}],"predecessor-version":[{"id":240960,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/240956\/revisions\/240960"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/240958"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=240956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=240956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=240956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}